Phase 1 Oligometastatic Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Trial of Oligometastasis SBRT With Immediate, Simulation-Free Treatment Delivery (OLIGO-SWIFT)

Oligometastatic DiseaseOligometastasis

Case Comprehensive Cancer Center15 enrolled1 locationNCT07079098

Recruiting

Phase 1Phase 2

Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

Solid Tumor, AdultOligometastatic Disease

Gustave Roussy, Cancer Campus, Grand Paris58 enrolled2 locationsNCT06439888